No decision aid replaces the conversation patients should have with their clinicians to make important, clinical decisions. Use of these decision aids carries no liability to its developers or to the Mayo Clinic Foundation for Education and Research. If you download our decision aids, we would love to hear from you! Please send us a note at kerunit@mayo.edu to let us know who you are, why you are interested in the decision aid(s), and how you plan to use them. Remember to check back to this page periodically to make sure you are using the most up-to-date version(s).
The Osteoporosis Choice decision aid conveys the pros and cons of treatment using an estimate of the patient’s risk of bone fracture.
Osteoporosis Choice: elevated risk
Osteoporosis Choice: high risk
The following publications report the findings of the Osteoporosis Choice decision aid trial:
- Montori VM, Shah ND, Pencille LJ, Branda ME, VanHouten HK, Swiglo BA, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Melton LJ, Wermers RA. Use of a decision aid to improve treatment decisions in osteoporosis: The Osteoporosis Choice randomized trial. Am J Med. 2011;124:549-556.
- Scoville EA, Ponce de Leon Lovaton P, Shah ND, Pencille LJ, Montori VM. Why do women reject bisphosphonates for osteoporosis? A videographic study. PLoS One. 2011;6:e18468.
- Pencille LJ, Campbell ME, VanHouten HK, Shah ND, Mullan RJ, Swiglo BA, Breslin M, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Wermers RA, Melton LJ, Montori VM. Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials. 2009;10:113.
